Risk factors regarding MS, including genetic research findings and progressive multifocal leukoencephalopathy while taking natalizumab, are discussed.
Our Feb. news & research include two new migraine drugs, the stroke-Parkinson link, and the potential of an anticancer drug to prevent Alzheimer.
Our Jan. news & research list includes the possible lingering effects of childhood concussion and the benefits of vitamin D for MS.
The risks and benefits of intravenous tissue plasminogen activator and endovascular thrombectomy are discussed in the following slides.
Our Dec. news & research list includes groundbreaking research from AES 2015 as well as a few potential neurodegeneration biomarkers.
Our Nov. news & research list includes 2 successful genetic Alzheimer treatments in mouse models and a potential drug for Parkinson disease psychosis.
The following slides discuss strokes: the role of job stress and the stress doctors feel when treating cryptogenic strokes.
Our Oct. list of news & research highlights MS – online fatigue management, positive phase III trials, vitamin D, & more.
Exercise to preserve cognitive function and use of biomarkers to aid rapid diagnosis are two topics covered in the following slides.
Our Sept. list of top news & research includes a therapy for drug-resistant epilepsy and promising medications for Parkinson and Alzheimer.